The National Institutes of Health launched a study to determine how many adults in the U.S. without a confirmed COVID-19 history have antibodies to the virus. By collecting blood samples from volunteers, researchers hope to model the degree to which the virus spread undetected in the U.S. “These crucial data will help us measure the impact of our public health efforts now and guide our COVID-19 response moving forward,” said Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases.

Related News Articles

Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…